Aflibercept in Combination With Docetaxel in Metastatic Androgen Independent Prostate Cancer

Clinical trial NCT00519285 · COMPLETED

Trial details

NCT number: NCT00519285
Sponsor: Sanofi
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Prostatic Neoplasms Neoplasm Metastasis

Start date: 2007-08-01
Primary completion: 2012-04-01
Enrollment: 1224

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.